Pfizer Inc’s drug – Revatio – is a PAH (Pulmonary Arterial Hypertension) drug that should not be used in children up to 17 years of age Revatio was never approved by the FDA (Food and Drug Administration) for treatment of PAH in children, although, the FDA is warning against “off-label” (non-FDA approved) use of the [...]